Corcept Therapeutics Inc (CORT)
25.21
-0.11
(-0.43%)
USD |
NASDAQ |
Mar 28, 16:00
25.19
-0.02
(-0.08%)
After-Hours: 20:00
Corcept Therapeutics Profit Margin (Quarterly): 23.16% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 23.16% |
September 30, 2023 | 25.39% |
June 30, 2023 | 23.39% |
March 31, 2023 | 15.03% |
December 31, 2022 | 16.11% |
September 30, 2022 | 34.02% |
June 30, 2022 | 26.51% |
March 31, 2022 | 24.33% |
December 31, 2021 | 32.44% |
September 30, 2021 | 31.70% |
June 30, 2021 | 28.96% |
March 31, 2021 | 29.54% |
December 31, 2020 | 30.32% |
September 30, 2020 | 25.05% |
June 30, 2020 | 31.98% |
March 31, 2020 | 32.24% |
December 31, 2019 | 33.43% |
September 30, 2019 | 32.32% |
June 30, 2019 | 27.94% |
March 31, 2019 | 28.19% |
December 31, 2018 | 32.93% |
September 30, 2018 | 27.54% |
June 30, 2018 | 29.20% |
March 31, 2018 | 30.28% |
December 31, 2017 |
Date | Value |
---|---|
September 30, 2017 | 32.17% |
June 30, 2017 | 35.57% |
March 31, 2017 | 15.90% |
December 31, 2016 | 19.31% |
September 30, 2016 | 11.90% |
June 30, 2016 | 4.95% |
March 31, 2016 | -0.12% |
December 31, 2015 | 6.41% |
September 30, 2015 | -4.53% |
June 30, 2015 | -16.19% |
March 31, 2015 | -47.81% |
December 31, 2014 | -43.21% |
September 30, 2014 | -82.48% |
June 30, 2014 | -129.1% |
March 31, 2014 | -316.2% |
December 31, 2013 | -270.3% |
September 30, 2013 | -414.0% |
June 30, 2013 | -629.1% |
March 31, 2013 | -703.8% |
December 31, 2012 | -807.8% |
September 30, 2012 | -786.1% |
June 30, 2012 | -868.2% |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
15.03%
Minimum
Mar 2023
34.02%
Maximum
Sep 2022
27.60%
Average
28.57%
Median
Profit Margin (Quarterly) Benchmarks
Puma Biotechnology Inc | 17.00% |
Anavex Life Sciences Corp | -- |
Ultragenyx Pharmaceutical Inc | -96.70% |
Voyager Therapeutics Inc | 62.62% |
Aditxt Inc | -7.83K% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 21.92% |
Return on Assets | 18.04% |
Return on Invested Capital | 21.92% |
Gross Profit Margin (Quarterly) | 98.61% |
Operating Margin (Quarterly) | 23.39% |
Return on Net Operating Assets | 189.0% |